Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/1999
12/29/1999EP0564645B1 Transformant cells for the prophylaxis or treatment of diseases caused by viruses, particularly pathogenic retroviruses
12/29/1999EP0556292B1 Hepatitis c virus asialoglycoproteins
12/29/1999EP0437547B1 Monoclonal antibodies against receptor-induced binding sites on ligands binding to proteins of the cytoadhesin super family
12/29/1999CN1240001A Mutants of streptococcal toxin C and methods of use
12/29/1999CN1240000A Polypeptides encoded by human lipase-like gene, compositions and methods
12/29/1999CN1047795C Method for producing taxol and taxanes from embryo cultures of taxus species
12/29/1999CA2335804A1 Allelic series of genomic modifications in cells
12/29/1999CA2335793A1 A method for in vitro maturation of human gametes
12/29/1999CA2335632A1 Assay to indicate the presence of non-fertilisable ova
12/29/1999CA2335585A1 Novel molecules of the t110-related protein family and uses thereof
12/29/1999CA2334767A1 Process for the in vitro replication of hcv
12/29/1999CA2331769A1 Prostate cancer-associated genes
12/29/1999CA2331326A1 Human glycoprotease-like proteins and dnas encoding these proteins
12/29/1999CA2330542A1 Human arf-related proteins
12/29/1999CA2330189A1 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore
12/29/1999CA2330175A1 Ependymal neural stem cells and method for their isolation
12/29/1999CA2329690A1 Methods to screen herbicidal compounds utilizing air synthetase from arabidopsis thaliana
12/28/1999US6008434 Rodents with mutated endogenous growth differentiation factor-11 gene; animals exhibiting a phenotype of increased muscle tissue; animal food products with high muscle and protein content, reduced fat and cholesterol
12/28/1999US6008340 Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules
12/28/1999US6008337 Polynucleotides encoding polypeptides; diagnosis and therpy for acquired immune disease syndrome, gout, addison's/crohn's diseases, adult respiratory distress syndrome, multiple sclerosis; antiarthritic/anticarcinogenic/antidiabetic agents
12/28/1999US6008197 Activating the freeze dried denatured cells with a denaturing agent solution; use as promoting bone healing or bone formation in mammal
12/28/1999US6008194 Human preprotachykinin B
12/28/1999US6008052 Preservation of cells as controls or standards in cellular analysis
12/28/1999US6008050 A polynucleotide encoding a polypeptide related to g protein coupled 7 transmembrane receptors; diagnosis/therapy of heart diseases, osteoporosis, anxiety, eating disorders, schizophrenia, ulcers, parkinson's/huntington's disease
12/28/1999US6008049 A device for culturing three-dimensional tissues in vitro having a housing unit that has a tissue disposed on a porous substrate between two different concentration of media, creating a diffusional gradient causing movement of solutes
12/28/1999US6008047 Cell culturing method and medium
12/28/1999US6008042 A polynucleotide; diagnosis and therapy for stroke, septic shock, acquired immune deficiency syndrome, osteoporosis, antiarthritic/antiinflammatory/antiischemic agents, genetic disorders; alzheimer's/parkinson's diseases
12/28/1999US6008040 Higher yields and purities by passing a fluid mixture through a separation media of porous membranes and graded particles with increasingly smaller diameters to create a cascading flow channel
12/28/1999US6008039 Polynucleotide encoding a novel purinergic P2U receptor
12/28/1999US6008035 System for the in vivo delivery and expression of heterologous genes in the bone marrow
12/28/1999US6008024 An protein which forms an immunological complex with a phosphorylated epitope of an antigen belonging to a paired helical filament-tau protein; diagnosis and therapy for alzheimer's disease
12/28/1999US6008017 Human cardiac/brain tolloid-like protein
12/28/1999US6008015 Glycine transporter
12/28/1999US6008010 Method and apparatus for holding cells
12/28/1999US6008004 Identification of a CD34+ bone marrow precursor for dendritic cells in blood and lymphoid tissues
12/28/1999US6007989 Methods of screening for compounds that derepress or increase telomerase activity
12/28/1999US6007981 Modifying target cells making them sensative to a toxin; transforming cells with a nucleotide sequences encoding a receptor that binds cryia toxin of bacillus, culturing cells allowing receptor expression on cell surface
12/28/1999US6007807 Hybrid fusion cell comprising idiotypic antibody-expressing malignant b cell fused to b cell hybridoma expressing an antibody which is internalized on an antigen presenting cell
12/28/1999US6006752 Mixed chimerism and tolerance
12/28/1999CA1340866C Human c3b/c4b receptor (cr1)
12/28/1999CA1340863C Domain-modified constant region antibodies
12/25/1999CA2241576A1 Efficient non-viral transduction and culture of erythroid cells
12/23/1999WO1999066060A1 Human mp52 gene promoter and method for exploring useful substance by using the same
12/23/1999WO1999066055A2 Plant pathogen inducible control sequences operably linked to cell cycle genes and the uses thereof
12/23/1999WO1999066054A2 Erythropoietin analog-human serum albumin fusion protein
12/23/1999WO1999066051A2 Nek-related and bub1-related protein kinases
12/23/1999WO1999066047A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999WO1999066044A1 Bactericidal/permeability-increasing protein (bpi) deletion analogs
12/23/1999WO1999066041A1 94 human secreted proteins
12/23/1999WO1999066040A1 Immunomodulator polypeptide, zsig57
12/23/1999WO1999066038A1 Angiostatin-binding protein
12/23/1999WO1999066036A1 Transplants for myocardial scars
12/23/1999WO1999066029A2 Gibberelin 2-oxidase
12/23/1999WO1999065947A2 Monoclonal antibodies directed against the g3bp protein, and uses
12/23/1999WO1999065940A1 Anti-angiogenic proteins and methods of use thereof
12/23/1999WO1999065937A2 Truncated apaf-1 and methods of use thereof
12/23/1999WO1999065924A2 Preparation and use of superior vaccines
12/23/1999WO1999065534A1 Three-dimensional prostheses containing hyaluronic acid derivatives
12/23/1999WO1999065503A1 Method of treating osteogenesis imperfecta
12/23/1999WO1999065299A1 Compositions and methods for expansion of hematopoietic cells
12/23/1999WO1999065293A1 A process for production and subsequent ex vitro sowing and propagation of pre-germinated plant somatic embryos
12/23/1999WO1999055832A3 Nucleic acid encoding rate agouti related protein
12/23/1999WO1999054493A3 Novel mutations in the freac3 gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis
12/23/1999WO1999053043A3 Herpes simplex virus latency associated transcript polypeptides
12/23/1999WO1999051741A3 Lyst protein complexes and lyst interacting proteins
12/23/1999WO1999050428A3 Pathogen-inducible promoter
12/23/1999WO1999049881A3 Application of hsp70 proteins
12/23/1999WO1999049876A3 Bacterial or yeast extracts which stimulate the production of defensins and methods of use thereof
12/23/1999WO1999047649A3 Polymerase chimeras
12/23/1999WO1999043830A9 Human platelet heparanase polypeptides, polynucleotide molecules that encode them, and methods for the identification of compounds that alter heparanase activity
12/23/1999WO1999042589A3 Insecticidal toxins from photorhabdus
12/23/1999WO1999042578A3 Modulation of cell proliferation, methods and reagents
12/23/1999WO1999041364A3 Compositions and methods for wound healing
12/23/1999WO1999038972A3 Human genes and gene expression products ii
12/23/1999WO1999033982A3 Human genes and gene expression products i
12/23/1999WO1999033869A3 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
12/23/1999WO1999028748A3 Hla-e binding
12/23/1999CA2341455A1 A process for production and subsequent ex vitro sowing and propagation of pre-germinated plant somatic embryos
12/23/1999CA2335452A1 Preparation and use of superior vaccines
12/23/1999CA2335248A1 Transplants for myocardial scars
12/23/1999CA2332173A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999CA2331889A1 Nek-related and bub1-related protein kinases
12/23/1999CA2331880A1 Bactericidal/permeability-increasing protein (bpi) deletion analogs
12/23/1999CA2331332A1 Anti-angiogenic proteins and methods of use thereof
12/23/1999CA2331253A1 Immunomodulator polypeptide, zsig57
12/23/1999CA2331154A1 Polypeptides having sequence identity with acid labile subunit of insulin-like growth factor
12/23/1999CA2331151A1 Monoclonal antibodies directed against the g3bp protein, and uses
12/23/1999CA2330842A1 Truncated apaf-1 and methods of use thereof
12/23/1999CA2330550A1 Plant pathogen inducible control sequences operably linked to cell cycle genes and the uses thereof
12/23/1999CA2330527A1 Erythropoietin analog-human serum albumin fusion
12/23/1999CA2330228A1 Angiostatin-binding protein
12/22/1999EP0965594A2 Nef-attachable protein, DNA encoding the protein and a monoclonal antibody against said protein
12/22/1999EP0965583A1 Polyamine compounds and compositions containing them useful for the transfer of active substances into a cell
12/22/1999EP0964927A1 Cassava vein mosaic virus promoters and uses thereof
12/22/1999EP0964925A2 A basal cell carcinoma tumor suppressor gene
12/22/1999EP0964921A1 Novel streptococcal ers
12/22/1999EP0964917A1 Age-1 polypeptides and related molecules and methods
12/22/1999EP0964915A1 $i(IN VIVO) APOPTOSIS SCREENING
12/22/1999EP0964875A1 5-hydroxytryptophol (5-htol) derivatives, antibodies, immunoassays and detection of recent alcohol consumption
12/22/1999EP0964874A1 A lymphocyte surface receptor that binds caml, nucleic acids encoding the same and methods of use thereof